Cost burden of chemotherapy for Indonesian healthcare insurance and social security/Jaminan Kesehatan Nasional (JKN) patients with non-Hodgkin lymphoma.

Yulistiani YulistianiErfan AbdissalamAbdul RahemNur Fauzi HamidiFebriansyah Nur Utomo

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)

Based on the results, the highest cost burden for chemotherapy among JKN patients with NHL in Indonesia was attributed to R-CHOP-Bleo regimen with a mean of IDR 8,764,091.

Keyphrases

healthcare
locally advanced
diffuse large b cell lymphoma
risk factors
health insurance
affordable care act
squamous cell carcinoma
rectal cancer
global health
radiation therapy
public health